Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PAICS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DIS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOCK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTHFD2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KNSTRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBDSP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZWILCH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRP72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASUN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDCA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC81691 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on